EWM
BIIB icon

Elite Wealth Management’s Biogen BIIB Stock Holding History

Elite Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,024
Closed -$298K – 46
2015
Q3 		$298K Buy
+1,024
New +$338K 0.47% 51
2014
Q1 		– Sell
-215
Closed -$60K – 358
2013
Q4 		$60K Buy
215
+162
+306% +$41.9K 0.04% 144
2013
Q3 		$13K Buy
+53
New +$11.9K 0.01% 286

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Elite Wealth Management's BIIB Position: Q4 2015 in Review

Elite Wealth Management sold out of Biogen (BIIB) in Q4 2015, closing a stake of 1,024 shares — an estimated $298K sold.

Elite Wealth Management first reported a position in BIIB in Q3 2013 and held it in 3 quarters. The position peaked at $298K in Q3 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Elite Wealth Management reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Elite Wealth Management sold 1,024 Biogen shares in Q4 2015, an estimated $298K.
  • Elite Wealth Management first reported a position in Biogen in Q3 2013 and held it in 3 quarters.
  • Elite Wealth Management's Biogen position peaked at $298K in Q3 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Elite Wealth Management's 13F filing for Q4 2015, filed 13 Oct 2016.